Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

De Novo Deletion of AFG3L2 Causing Spinocerebellar Ataxia Type 28 in the Context of Multiple Genomic Anomalies
Movement Disorders
(-)
046
Authors/Disclosures
Ken Myers, MD, PhD (Montreal Children'S Hospital/McGill University Health Centre)
PRESENTER
Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Myers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AS2Bio. The institution of Dr. Myers has received research support from Fonds de Recherche de Santé Québec. The institution of Dr. Myers has received research support from Liam Foundation. The institution of Dr. Myers has received research support from Pediatric Research Foundation. The institution of Dr. Myers has received research support from Montreal Children's Hospital Foundation. The institution of Dr. Myers has received research support from CQDM/Pharma Liam. The institution of Dr. Myers has received research support from CIHR.
Claudia Prada No disclosure on file
Jodi W. Chardon No disclosure on file
Kym Boycott No disclosure on file